Sort

Search

01/01/2023 Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Pérez de Llano L., Cisneros C., Domínguez-Ortega J., Martínez-Moragón E., Olaguibel J.M., Plaza V., Quirce S., Dávila I.. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(1)DOI:10.18176/jiaci.0857. PMID:36040046. IF:6.700(Q1/2D).
01/01/2023 Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids
Gil-Martínez M., Lorente-Sorolla C., Rodrigo-Muñoz J.M., Lendínez M.Á., Núñez-Moreno G., de la Fuente L., Mínguez P., Mahíllo-Fernández I., Sastre J., Valverde-Monge M., Quirce S., Caballero M.L., González-Barcala F.J., Arismendi E., Bobolea I., Valero A., Muñoz X., Cruz M.J., Martínez-Rivera C., Plaza V., Olaguibel J.M., del Pozo V.. Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(2)DOI:10.3390/ijms24021611. PMID:36675122. IF:4.900(Q1/3D).
01/01/2023 Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia
Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(1)DOI:10.1016/j.arbres.2022.07.011. PMID:35970652. IF:8.700(Q1/1D).
01/01/2023 Economic Consequences of the Overuse of Short-Acting ?-Adrenergic Agonists in the Treatment of Asthma in Spain
Valero A., Molina J., Nuevo J., Simon S., Capel M., Sicras-Mainar A., Sicras-Navarro A., Plaza V.. Economic Consequences of the Overuse of Short-Acting ?-Adrenergic Agonists in the Treatment of Asthma in Spain. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(2)DOI:10.18176/jiaci.0767. PMID:34825651. IF:6.700(Q1/2D).